Program

CO30-004

Oral Communication

Vegetative effects of botulinum toxin in spasticity treatment of stroke patients.

Dr Charlotte CHOTARDa, Dr Evelyne CASTEL-LACANALa, Prof Xavier DE BOISSEZONa, Prof Philippe MARQUEa, Prof Jean-Michel SENARDb, Dr Marc LABRUNEEc

a Service de Médecine Physique et de Réadaptation, CHU Toulouse, b Service de Pharmacologie Clinique, CHU TOULOUSE, c Service de Médecine Physique et de Réadaptation, Unité de Réadaptation cardiaque, CHU TOULOUSE

Introduction

Botulinum toxin (BT) injected into the skeletal muscle is the reference treatment of focal spasticity. It induces blockade of the presynaptic release of acetylcholine causing a decrease in muscle contraction. Three kinds of general complications are reported: flu-like syndrome, fatigue and generalised botulism. Their physiopathological mechanisms are not well known, neither is the mechanism of BT diffusion. Along with this, there is evidence of retrograde transport of the toxin via the neuron since authors found the toxin, injected in peripheral muscle, in the central nervous system. Moreover, acetylcholine is a neurotransmitter in common for the sensorimotor system and the vegetative system. This retrograde transport is the cause of a motor effect on adjacent muscles to the injected muscle. However, we do not know the impact on the autonomic nervous system of the central location of the toxin.

Objective

Test the hypothesis of cardiovascular autonomic effects of BT injected into the peripheral muscle in a population of stroke patients who need spasticity focal treatment.

Material and Methods

Twenty chronic hemiparetic patients will be tested. Our experimental setting includes: spontaneous baroreflex study, spectral analysis of sinusal variability, Finapres recording of heart rate and blood pressure during Ewing maneuvers, sudoral function with SUDOSCAN. We take these measures the day of injection, then 6 weeks later, which is the peak of TB muscular efficiency and 6 months later.

Results

Preliminary results on 5 spastic hemiparetic patients (mean age = 46, 6 years old; delay time from stroke = 3,7 years) evaluated the day of injection and 6 weeks later found significant higher HR and BP at rest, without significant differences of sinusal variability nor Ewing score (baroreflex study analysis in process).

Discussion

This pilot study is the first one which analyses the link between autonomic system and BT injected in the skeletal muscle in the context of focal treatment of spasticity in a population of stroke patients.

Keywords : botulinum toxin, stroke, vegetative system